{"title":"Chicken or egg? The role of dysbiosis in intestinal carriage of carbapenemase-producing Enterobacterales","authors":"M.J.S. Knudsen , F.H. Jensen , I.M.C. Rubin , A.M. Petersen","doi":"10.1016/j.jhin.2025.06.018","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Carbapenemase-producing Enterobacterales (CPE) have a well-established capability of spreading in healthcare environments and cause outbreaks in hospital wards.</div></div><div><h3>Aim</h3><div>To determine whether intestinal dysbiosis is associated with intestinal carriage of CPE; also to investigate treatment with antibiotics, and hospitalization prior to study inclusion.</div></div><div><h3>Methods</h3><div>A systematic search of the PubMed, Embase, and Cochrane databases was conducted in September 2024, and studies were included where the authors compared microbiome analysis of CPE carriers with microbiome analysis of non-carriers.</div></div><div><h3>Findings</h3><div>The search resulted in 1812 records. After removing duplicates, and non-eligible records based on title and abstract screening, 67 records were retrieved for full-text screening. Of these, four studies were included in the systematic review including 140 CPE carriers and 141 controls. In three studies the authors found dysbiosis in the group of CPE carriers, and in the fourth study they found a decrease in diversity in CPE carriers compared with healthy adults; however, there was no decrease in diversity compared with hospitalized non-carriers.</div></div><div><h3>Conclusion</h3><div>This systematic review has revealed an association between intestinal dysbiosis and intestinal carriage of CPE. Nonetheless, the potential influence of antibiotic treatment on this result cannot be dismissed.</div></div>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":"164 ","pages":"Pages 64-71"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hospital Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0195670125002038","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Carbapenemase-producing Enterobacterales (CPE) have a well-established capability of spreading in healthcare environments and cause outbreaks in hospital wards.
Aim
To determine whether intestinal dysbiosis is associated with intestinal carriage of CPE; also to investigate treatment with antibiotics, and hospitalization prior to study inclusion.
Methods
A systematic search of the PubMed, Embase, and Cochrane databases was conducted in September 2024, and studies were included where the authors compared microbiome analysis of CPE carriers with microbiome analysis of non-carriers.
Findings
The search resulted in 1812 records. After removing duplicates, and non-eligible records based on title and abstract screening, 67 records were retrieved for full-text screening. Of these, four studies were included in the systematic review including 140 CPE carriers and 141 controls. In three studies the authors found dysbiosis in the group of CPE carriers, and in the fourth study they found a decrease in diversity in CPE carriers compared with healthy adults; however, there was no decrease in diversity compared with hospitalized non-carriers.
Conclusion
This systematic review has revealed an association between intestinal dysbiosis and intestinal carriage of CPE. Nonetheless, the potential influence of antibiotic treatment on this result cannot be dismissed.
期刊介绍:
The Journal of Hospital Infection is the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience.
The Journal welcomes submissions that relate to all aspects of infection prevention and control in healthcare settings. This includes submissions that:
provide new insight into the epidemiology, surveillance, or prevention and control of healthcare-associated infections and antimicrobial resistance in healthcare settings;
provide new insight into cleaning, disinfection and decontamination;
provide new insight into the design of healthcare premises;
describe novel aspects of outbreaks of infection;
throw light on techniques for effective antimicrobial stewardship;
describe novel techniques (laboratory-based or point of care) for the detection of infection or antimicrobial resistance in the healthcare setting, particularly if these can be used to facilitate infection prevention and control;
improve understanding of the motivations of safe healthcare behaviour, or describe techniques for achieving behavioural and cultural change;
improve understanding of the use of IT systems in infection surveillance and prevention and control.